Hologic (HOLX)
(Delayed Data from NSDQ)
$75.98 USD
+0.27 (0.36%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $75.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HOLX 75.98 +0.27(0.36%)
Will HOLX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HOLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HOLX
3 Medical Products Stocks Set to Beat This Earnings Season
Hologic (HOLX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
HOLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note
Other News for HOLX
Goldman’s buybacks basket: Buyback growth will be 13% in 2024
Agree To Purchase Hologic At $55, Earn 1.6% Annualized Using Options
ClearBridge Appreciation ESG Strategy Q1 2024 Portfolio Manager Commentary
ClearBridge Sustainability Leaders Strategy Q1 2024 Portfolio Manager Commentary
Hologic Inc. stock underperforms Tuesday when compared to competitors